![]() |
Volumn , Issue , 2013, Pages
|
Developments in the use of antibody-drug conjugates
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY CONJUGATE;
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
NEW DRUG;
TUMOR ANTIGEN;
TUMOR PROTEIN;
ANIMAL;
CHEMISTRY;
CLINICAL TRIAL (TOPIC);
DRUG DESIGN;
DRUG SCREENING;
HUMAN;
IMMUNOLOGY;
NEOPLASMS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DRUG DESIGN;
DRUG SCREENING ASSAYS, ANTITUMOR;
DRUGS, INVESTIGATIONAL;
HUMANS;
IMMUNOCONJUGATES;
NEOPLASM PROTEINS;
NEOPLASMS;
|
EID: 84952334140
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.1200/EdBook_AM.2013.33.e99 Document Type: Review |
Times cited : (5)
|
References (0)
|